GlaxoSmithKline (GSK) has appointed Luke Miels as its next chief executive, effective January 1, 2026. He will also join the company’s board on that date. Background And Role Miels currently serves as GSK’s Chief Commercial Officer, overseeing global medicines and vaccine businesses. He joined
